A single center, retrospective study of Belatacept and Tacrolimus in kidney transplant recipients who are infected with Sars-Cov-2
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Belatacept (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 07 Jul 2021 New trial record
- 09 Jun 2021 Results presented at the 2021 American Transplant Congress